Evidence and identity guide · Sources checked October 18, 2026
The short answer
5-Amino-1MQ is a small molecule based on a methylquinolinium structure, not a chain of amino-acid residues. Its name includes an amino group, but that is not the same thing as being an amino acid or a peptide. Appearing in a peptide supplier’s catalog does not change its chemical category.
This distinction is more than a vocabulary correction. It affects which literature is relevant, what identity information to request, and which assumptions should stay out of a research comparison.
“Amino” and “peptide” describe different things
A peptide contains amino-acid-derived units connected through peptide bonds. IUPAC’s definition focuses on that chemical linkage, rather than where a product is sold or whether its name contains the word amino. A molecule can contain an amino group without having a peptide backbone. See IUPAC’s peptide definition.
For 5-Amino-1MQ, the name points to an amino substituent on a methylquinolinium framework. It does not describe five amino acids joined together. “5” identifies a position in the chemical name; it is not a residue count. There is therefore no peptide sequence to read in the way one would read a sequence for a peptide.
A useful mental distinction is structure versus label category. “Research material” describes a context. “Small molecule” or “peptide” describes chemistry. A shared storefront collection can contain both, just as one laboratory can work with many different kinds of compounds.
Where NNMT enters the story
NNMT stands for nicotinamide N-methyltransferase, an enzyme. The 2017 structure–activity study by Neelakantan and colleagues screened related chemical frameworks and investigated how structural differences related to NNMT inhibition. Quinolinium compounds were among the scaffolds examined. This is the medicinal-chemistry context for the name, rather than evidence that 5-Amino-1MQ belongs to a peptide family. Read the original structure–activity study.
“Inhibitor” describes an experimentally observed interaction under specified conditions. It is not a synonym for supplement, treatment, or a guaranteed effect in every biological setting. When comparing inhibitors, the assay and its controls belong beside the compound name. A single potency figure without those details is an incomplete description.
What the later experiments add
A subsequent paper investigated membrane permeability, biochemical selectivity and effects in cellular and mouse models. These are different experimental questions: access to a cell, effects on an enzyme, and changes in a whole organism should not be compressed into one claim that the material “works.” The paper provides preclinical evidence, not a demonstration that a commercial vial is effective or safe for people. Read the primary experimental paper.
Even a positive result in a model leaves a translation question. A laboratory observation does not identify a human dose, establish a suitable route of administration, or verify an oral or sublingual formulation. No such instructions or absorption claims follow from this identity guide.
Read the material specification, not the category tag
For a research purchase, start with the complete chemical identity and documented form. An abbreviated title can help locate a listing, but it should not be the only record carried into an experiment. The following questions form a practical purchasing checklist, not a claim that any particular batch already satisfies it:
- Full identity: Does the specification name the compound explicitly rather than only calling it an NNMT inhibitor?
- Form: Is the counterion or salt form documented, and does it match the reference material?
- Quantity: What does the labeled mass refer to? Avoid assuming the answer when the basis is unstated.
- Lot link: Can the analytical record be associated with the particular lot being considered?
- Method: Does the documentation explain what the reported measurement actually tests?
These questions prevent a category error from becoming a purchasing error. Two entries can share a familiar abbreviation while leaving important specification details unresolved. Conversely, a precise identity does not itself supply missing biological evidence. Chemical characterization and experimental performance are separate records.
Common questions
Does the 5 mean five amino acids?
No. In this name it is a chemical position, not the length of a peptide chain.
Is 5-Amino-1MQ the same as NNMT?
No. NNMT is the enzyme being studied; 5-Amino-1MQ is a small molecule investigated as an inhibitor.
Can peptide storage or formulation guidance be copied across?
Not merely because both products are cataloged together. Use material-specific documentation and a qualified laboratory protocol rather than borrowing instructions from a different chemical class.
Does correcting the classification establish safety?
No. Knowing what kind of molecule something is does not resolve its toxicology, legal status or suitability for any intended application.
Find the named research material
Dissolv lists 5-Amino-1MQ 10mg. The number in the listing describes the labeled presentation, not a recommended dose. Confirm the exact chemical form and current lot documentation before deciding whether it matches an authorized laboratory project.
For laboratory research only. Not for human or veterinary use. This link does not imply therapeutic suitability, clinical equivalence or independent verification of the supplied lot.
Sources
- IUPAC Gold Book: peptides
- Neelakantan et al., 2017: structure–activity relationship of small-molecule NNMT inhibitors
- Neelakantan et al., 2018: selective, membrane-permeable NNMT inhibitors in preclinical models
Educational synthesis prepared with AI assistance. This is not a systematic review or medical advice. Product links lead to Dissolv’s own catalog.
